Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin in perioperative analgesia for hip/knee joint replacement
ChiCTR2300072126Phase 4Not yet recruiting
- Sponsor
- Tianjin Jizhou District People's Hospital
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ulinastatin in postoperative pain (2 arms), sponsored by Tianjin Jizhou District People's Hospital. Primary endpoint: Postoperative morphine consumption. Planned start May 2023; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300072126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072126.